U-M's Taubman Institute Awards $100K Medical Research Prize

Harry Dietz awarded for advances in translational medical research


Published:

ANN ARBOR — The inaugural $100,000 Taubman Prize for Excellence in Translational Medical Science has been awarded to Harry Dietz, M.D., of Johns Hopkins University, the University of Michigan’s A. Alfred Taubman Medical Research Institute announced Monday.

Dietz, a cardiologist and genetics researcher, has made groundbreaking progress in the understanding of aortic aneurysm and related tissue disorders. His lab is the first to determine that some defects in the human body’s connective tissue, long thought to be unchangeable, can be modified with medication. The discovery has overturned decades of conventional wisdom and has tremendous implications for the treatment of genetic connective tissue disorders.

Alfred Taubman, founder and chair of the A. Alfred Taubman Medical Research Institute, said, “Dr. Dietz exemplifies the passion and persistence of physician-scientists everywhere.”

The Taubman Prize was established to annually recognize the clinician-researcher who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease. “In honoring Dr. Dietz, [a well-known] scientist whose landmark findings may improve quality of life for tens of thousands of people, I am confident that we have accomplished our goal.”

Eva Feldman, M.D., Ph.D., director of the Taubman Institute and the Russell N. DeJong Professor of Neurology at the U-M Medical School, remarked that the selection committee unanimously agreed to award him the Taubman Prize. “Researchers like Dr. Dietz are truly scientists who create cures.”

Dietz, a professor of pediatric cardiology and genetics expert at the Johns Hopkins University School of Medicine and a Howard Hughes Medical Institute investigator, began his research career studying Marfan syndrome. The syndrome enlarges the aorta, the largest blood vessel in the body, which makes it more inclined to tear or burst: an often fatal event that affects about one in 5,000 people.

In studying Marfan syndrome and related disorders at the molecular level, Dietz and his team made the key discovery that this condition is responsive to medication. Up until then, physicians had believed that manifestations of these disorders would be difficult or impossible to modify.

Dietz’s research has led to a clinical trial using the blood pressure drug losartan in Marfan syndrome patients at risk for aortic aneurysm, which is currently taking place at 20 sites in the United States, Canada, and Belgium. Testing on mice in Dietz’s lab and in a smaller group of human subjects indicated that the drug dramatically slows the enlargement of the aorta, though Dietz has cautioned that full results of the broader trial will be needed to assess losartan’s effectiveness.

Dietz said the prize will spotlight the importance of translational medical research. His team and other scientists around the world are now positioned to find new treatments for not only Marfan patients, but also for disorders such as aortic aneurysm, pulmonary emphysema, fibrosis, heart valve disease, and skeletal muscle myopathy.

"I am deeply honored to receive the Taubman Prize and equally thrilled by the prospect that this high-profile mechanism to recognize excellence in translational science will stimulate both interest and progress in this important field," he said.

A national selection committee reviewed more than 30 nominations for the 2012 Taubman Prize.

Dietz will receive the $100,000 grant to further his research and will appear as keynote speaker Oct. 11, 2012 at the Taubman Institute’s annual symposium in Ann Arbor.

Nominations for the 2013 Taubman Prize are now being accepted. For more information and judging criteria, visit the Taubman Institute website at www.taubmaninstitute.org.

Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Related Articles

The Fountain Restaurant Rolls into Campus Marius

The Fountain Detroit, a restaurant and bar arrived in the unique beach area at Campus Maritus Park this morning in preparation for the 2016 summer season.

Giant Hot Dog Added to Mackinaw City Diner

Pilot Progam Launched to Promote Healthy Lifestyles in Communities

A new community-based pilot project to promote healthy behaviors and lifestyles within communities has launched in Royal Oak.

Alaskan Outfitter Opens First Michigan Store in Detroit

Filson, a Seattle-based manufacturer and outfitter, has opened the doors to its first Michigan store in Midtown Detroit today.

The Townsend Hotel Unveils Final Phase of Renovations

The Townsend Hotel , an award winning and luxury hotel in Birmingham, is unveiling plans for the final phase of its ongoing modern luxury makeover, which began in 2012.
Edit ModuleShow Tags

Most Popular

  1. Ann Arbor’s TITLE Boxing Club Adds New Owners
    Ann Arbor-based TITLE Boxing Club International— which has grown to 150 boxing clubs from 20...
  2. Detroit Denim Co. Opens New Location, Launches Additional Product Lines
    Described as a new manufacturing center in the Motor City, Detroit Denim Co. opens its new...
  3. Detroit’s Metropolitan Building to be Converted into Extended-stay Hotel
    Starwood Hotels & Resorts Worldwide Inc. and two local partners will convert the historic...
  4. Detroit Historic Scarab Club to Launch Major Rebranding Campaign
    The Scarab Club in Detroit’s Midtown district will unveil a major rebranding campaign in early...
  5. 3 Beaumont Hospitals to Offer Non-Emergency Heart Procedure
    Beaumont hospitals in Farmington Hills, Trenton, and Wayne have earned approvals to perform...
  6. GM Unveils Luxury Edition of 2016 GMC Yukon
    General Motors Co. today revealed the 2016 GMC Yukon SLT Premium Edition, a more luxurious...